Press Release - 2026-04-02
Press Release - 2026-03-25
Seaport Therapeutics Announces Science Translational Medicine Peer-Reviewed Publication Featuring GlyphAllo (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
Press Release - 2026-03-03
Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele, the First Oral Therapeutic Designed to Restore Gut Lymphatic Function
Press Release - 2026-02-20
Seaport Therapeutics Presents New Meta-Analysis Examining the Impact of Clinical Trial Design Factors on Placebo Response in Generalized Anxiety Disorder Trials
Press Release - 2026-02-18
Seaport Therapeutics to Participate in Upcoming Investor Conferences in February and March
Press Release - 2026-01-05
Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Press Release - 2025-12-08
Seaport Therapeutics Presents Data Further Validating GlyphTM Platform’s Ability to Enhance Oral Bioavailability and Expand Therapeutic Reach
Press Release - 2025-12-04
Seaport Therapeutics to Present at 2025 RBC Capital Markets Healthcare Private Company Conference
Press Release - 2025-11-04
Seaport Therapeutics to Present at Stifel 2025 Healthcare Conference
Press Release - 2025-09-18
